Loading...
Keywords
Last Name
Institution

Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.

White KL, Vierkant RA, Phelan CM, Fridley BL, Anderson S, Knutson KL, Schildkraut JM, Cunningham JM, Kelemen LE, Pankratz VS, Rider DN, Liebow M, Hartmann LC, Sellers TA, Goode EL. Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer. BMC Cancer. 2009 Jun 06; 9:170.

View in: PubMed

collapse authors with profiles